Protherics share prices soars on back of potential takeover
This article was originally published in Scrip
Executive Summary
Protherics' share price has soared following news that that the UK-based biopharmaceutical company has received acquisition offers. The price rose by 65% from the previous day to close at $8.75 on Nasdaq on August 13th.